Gene	Mutation	ProtMut	MutReads	WTReads	VAF	Info
ASXL1	chr20:32366465-32367727_Del:AGA	S47_Del:R	3	59	0.048	Neutral
CEBPA	chr19:33301506-33301506_Ins:GAAG	R306fs*15	27	230	0.105	Oncogenic
CEBPA	chr19:33301525-33301525_Sub:C>T	R297H	5	209	0.023	Oncogenic
CEBPA	chr19:33301973-33301973_Sub:C>A	E148*	9	21	0.300	Oncogenic
CSF3R	chr1:36467309-36467311_Del:CTG	R653-K654_Del:NR	23	341	0.063	Neutral
ETV6	chr12:11650159-11752450_Del:AGC	E12_Del:Q	6	89	0.063	Neutral
ETV6	chr12:11752562-11752562_Sub:G>A	R49H	30	86	0.259	Neutral
EZH2	chr7:148807701-148807706_Del:CTGTAT	Y732-S733_Del:RY	20	0	1.000	Neutral
FLT3	chr13:28014452-28015701_ITD	A952-M953_Ins:ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA	10	371	0.026	Oncogenic
FLT3	chr13:28023477-28028284_ITD	E762-D763_Ins:ERADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSE	13	226	0.054	Oncogenic
FLT3	chr13:28023477-28028287_ITD	E762-D763_Ins:EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSE	13	226	0.054	Oncogenic
FLT3	chr13:28050157-28050157_Sub:G>A	T227M	166	149	0.527	Neutral
GATA2	chr3:128486108-128486108_Sub:C>T	A164T	51	94	0.352	Neutral
GNAS	chr20:58898985-58898985_Ins:GCA	G728-E729_Ins:S	22	121	0.154	Neutral
IDH1	chr2:208243593-208243593_Sub:C>T	V178I	40	49	0.449	Neutral
IDH1	chr2:208243602-208243604_Del:CTT	G174_Del:E	3	100	0.029	Neutral
IDH1	chr2:208251539-208251539_Ins:T	I5fs*12	3	130	0.023	Sequencing_artefact
JAK2	chr9:5069060-5069060_Ins:A	N457fs*1	3	44	0.064	Sequencing_artefact
KIT	chr4:54699764-54699764_Ins:CAG	Q251-T252_Ins:Q	55	412	0.118	Neutral
KIT	chr4:54729384-54729384_Ins:T	L682fs*5	10	283	0.034	Sequencing_artefact
KIT	chr4:54729485-54731329_Del:GCA	D715_Del:S	80	273	0.227	Neutral
KMT2A	chr11:118472296-118472296_Ins:A	A383fs*5	5	32	0.135	Sequencing_artefact
KMT2A	chr11:118491308-118491316_Del:AGGTACAGA	T1604-D1606_Del:GTE	25	3	0.893	Neutral
KMT2A	chr11:118505200-118505200_Ins:A	I3105fs*7	3	12	0.200	Sequencing_artefact
NPM1	chr5:171392817-171392817_Ins:A	V156fs*5	55	2255	0.024	Sequencing_artefact
NPM1	chr5:171392914-171392914_Ins:A	V156fs*5	89	2285	0.037	Sequencing_artefact
PHF6	chrX:134393951-134393951_Ins:AGC	A139-D140_Ins:A	4	44	0.083	Neutral
RUNX1	chr21:34880587-34880587_Sub:C>G	D160H	41	16	0.719	Neutral
RUNX1	chr21:34880621-34880621_Ins:GGTA	A149fs*11	8	66	0.108	Oncogenic
SETBP1	chr18:44952728-44952728_Sub:C>A	P1130T	10	5	0.667	Neutral
SF3B1	chr2:197401451-197401451_Ins:A	F815fs*1	39	301	0.115	Sequencing_artefact
SF3B1	chr2:197416765-197416765_Ins:T	K214fs*20	24	275	0.080	Sequencing_artefact
STAG2	chrX:124025891-124025891_Ins:A	N34fs*10	5	134	0.036	Sequencing_artefact
STAG2	chrX:124030967-124030967_Ins:A	G46fs*40	11	94	0.105	Sequencing_artefact
STAG2	chrX:124057955-124057955_Ins:T	F468fs*4	9	129	0.065	Sequencing_artefact
TET2	chr4:105275794-105275794_Sub:A>G	I1762V	15	19	0.441	Neutral
TP53	chr17:7676154-7676154_Sub:G>C	P72R	113	96	0.541	Neutral
ZRSR2	chrX:15803779-15803779_Sub:C>T	R99W	3	27	0.100	Neutral
ZRSR2	chrX:15803783-15803783_Sub:A>T	Q100L	3	25	0.107	Neutral